Clinical Trials Browser

Phase 1/2 × Mutagenesis, Insertional × 1 year × Clear all

NCT05502367 2026-02-19

A Study of ABI-2280 Vaginal Insert (Previously Referred to as ABI-2280 Vaginal Tablet) in Participants With Cervical Intraepithelial Neoplasia

Phase 1/2 Terminated

Uterine Cervical Dysplasia